BEX2 and cholangiocarcinoma: As HuCCT1 cells could proliferate but cannot develop heterogenous tissue in mice, we stained newly established cholangiocarcinoma-xenografted samples (CHOL4) with anti-BEX2 and anti-Ki67 antibody and got similar results (Fig. 3D).